Emerging insights into liver-directed cell therapy for genetic and acquired disorders

Sanjeev Gupta, Mari Inada, Brigid Joseph, Vinay Kumaran, Daniel Benten

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Treatment of acute or chronic liver diseases by cell transplantation is an attractive prospect because organ shortages greatly restrict liver transplantation. Moreover, a variety of genetic deficiency states affecting extrahepatic organs are amenable to liver-directed cell therapy. While the initial clinical experience with liver cell transplantation has been encouraging, further advances in several areas are necessary to improve these results. Insights into how engraftment and proliferation of transplanted cells may be modulated to obtain therapeutically effective masses of transplanted cells will be important in this pursuit. Studies of cell therapy in animal models of specific diseases have provided insights into the development of clinically relevant strategies for various disorders. Also, identification of suitable cell types, including stem/progenitor cells that could be expanded and manipulated in cell culture conditions, has begun to provide important new information for cell therapy. Similarly, advances in cryopreservation of cells and prevention of allograft rejection offer ways to accomplish cell therapy in an effective manner. Taken together, these advances indicate that liver-directed cell therapy will be well positioned in the near future to play significant roles in transplantation medicine.

Original languageEnglish (US)
Pages (from-to)289-302
Number of pages14
JournalTransplant Immunology
Volume12
Issue number3-4
DOIs
StatePublished - Apr 2004

Fingerprint

Inborn Genetic Diseases
Cell- and Tissue-Based Therapy
Liver
Cell Transplantation
Liver Transplantation
Stem Cells
Animal Disease Models
Cryopreservation
Allografts
Liver Diseases
Chronic Disease
Cell Culture Techniques
Transplantation
Cell Proliferation
Medicine

Keywords

  • Cell
  • Cell therapy
  • Gene therapy
  • Liver
  • Transplantation

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Transplantation

Cite this

Emerging insights into liver-directed cell therapy for genetic and acquired disorders. / Gupta, Sanjeev; Inada, Mari; Joseph, Brigid; Kumaran, Vinay; Benten, Daniel.

In: Transplant Immunology, Vol. 12, No. 3-4, 04.2004, p. 289-302.

Research output: Contribution to journalArticle

Gupta, Sanjeev ; Inada, Mari ; Joseph, Brigid ; Kumaran, Vinay ; Benten, Daniel. / Emerging insights into liver-directed cell therapy for genetic and acquired disorders. In: Transplant Immunology. 2004 ; Vol. 12, No. 3-4. pp. 289-302.
@article{5d4f64dd94a14dbbbbaf7ba2f9cd6ee2,
title = "Emerging insights into liver-directed cell therapy for genetic and acquired disorders",
abstract = "Treatment of acute or chronic liver diseases by cell transplantation is an attractive prospect because organ shortages greatly restrict liver transplantation. Moreover, a variety of genetic deficiency states affecting extrahepatic organs are amenable to liver-directed cell therapy. While the initial clinical experience with liver cell transplantation has been encouraging, further advances in several areas are necessary to improve these results. Insights into how engraftment and proliferation of transplanted cells may be modulated to obtain therapeutically effective masses of transplanted cells will be important in this pursuit. Studies of cell therapy in animal models of specific diseases have provided insights into the development of clinically relevant strategies for various disorders. Also, identification of suitable cell types, including stem/progenitor cells that could be expanded and manipulated in cell culture conditions, has begun to provide important new information for cell therapy. Similarly, advances in cryopreservation of cells and prevention of allograft rejection offer ways to accomplish cell therapy in an effective manner. Taken together, these advances indicate that liver-directed cell therapy will be well positioned in the near future to play significant roles in transplantation medicine.",
keywords = "Cell, Cell therapy, Gene therapy, Liver, Transplantation",
author = "Sanjeev Gupta and Mari Inada and Brigid Joseph and Vinay Kumaran and Daniel Benten",
year = "2004",
month = "4",
doi = "10.1016/j.trim.2003.12.014",
language = "English (US)",
volume = "12",
pages = "289--302",
journal = "Transplant Immunology",
issn = "0966-3274",
publisher = "Elsevier",
number = "3-4",

}

TY - JOUR

T1 - Emerging insights into liver-directed cell therapy for genetic and acquired disorders

AU - Gupta, Sanjeev

AU - Inada, Mari

AU - Joseph, Brigid

AU - Kumaran, Vinay

AU - Benten, Daniel

PY - 2004/4

Y1 - 2004/4

N2 - Treatment of acute or chronic liver diseases by cell transplantation is an attractive prospect because organ shortages greatly restrict liver transplantation. Moreover, a variety of genetic deficiency states affecting extrahepatic organs are amenable to liver-directed cell therapy. While the initial clinical experience with liver cell transplantation has been encouraging, further advances in several areas are necessary to improve these results. Insights into how engraftment and proliferation of transplanted cells may be modulated to obtain therapeutically effective masses of transplanted cells will be important in this pursuit. Studies of cell therapy in animal models of specific diseases have provided insights into the development of clinically relevant strategies for various disorders. Also, identification of suitable cell types, including stem/progenitor cells that could be expanded and manipulated in cell culture conditions, has begun to provide important new information for cell therapy. Similarly, advances in cryopreservation of cells and prevention of allograft rejection offer ways to accomplish cell therapy in an effective manner. Taken together, these advances indicate that liver-directed cell therapy will be well positioned in the near future to play significant roles in transplantation medicine.

AB - Treatment of acute or chronic liver diseases by cell transplantation is an attractive prospect because organ shortages greatly restrict liver transplantation. Moreover, a variety of genetic deficiency states affecting extrahepatic organs are amenable to liver-directed cell therapy. While the initial clinical experience with liver cell transplantation has been encouraging, further advances in several areas are necessary to improve these results. Insights into how engraftment and proliferation of transplanted cells may be modulated to obtain therapeutically effective masses of transplanted cells will be important in this pursuit. Studies of cell therapy in animal models of specific diseases have provided insights into the development of clinically relevant strategies for various disorders. Also, identification of suitable cell types, including stem/progenitor cells that could be expanded and manipulated in cell culture conditions, has begun to provide important new information for cell therapy. Similarly, advances in cryopreservation of cells and prevention of allograft rejection offer ways to accomplish cell therapy in an effective manner. Taken together, these advances indicate that liver-directed cell therapy will be well positioned in the near future to play significant roles in transplantation medicine.

KW - Cell

KW - Cell therapy

KW - Gene therapy

KW - Liver

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=2442454652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442454652&partnerID=8YFLogxK

U2 - 10.1016/j.trim.2003.12.014

DO - 10.1016/j.trim.2003.12.014

M3 - Article

VL - 12

SP - 289

EP - 302

JO - Transplant Immunology

JF - Transplant Immunology

SN - 0966-3274

IS - 3-4

ER -